Here, we review key MAM interactions and proteins both in vitro and in vivo models of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. This evidence concerns the gene SGCG and early-onset autosomal dominant Alzheimer disease.